The World Health Organization (WHO) has set an ambitious goal of eliminating viral hepatitis by 20301.

​

At Gilead, we are working to be ahead of this target by actively supporting the efforts of governments, patient organisations, payers and healthcare providers to increase awareness, drive screening and facilitate linkage to care worldwide.

 

As part of our extensive commitment to this goal, we are absolutely delighted to be working with the NHS Addictions Provider Alliance and the HEP C U Later Programme across England in support of our jointly held ambition to eliminate across services by 2023.

​

To find out more about Gilead’s Elimination Initiatives or request Patient Support Information, Educational or Disease Awareness Materials please email: UKIPAC@gilead.com